RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Firas Kobaissy to Naltrexone

Back to Details
This is a "connection" page, showing publications Firas Kobaissy has written about Naltrexone.
Firas Kobaissy
Connection Strength
0.053
Naltrexone
  1. El Hayek SA, Shatila MA, Adnan JA, Geagea LE, Kobeissy F, Talih FR. Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia? Expert Rev Neurother. 2022 09; 22(9):737-749.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support